 |
Journal articles
Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinoma
Abstract : Hepatitis C virus (HCV) infection is associated with a high risk of developing hepatocellular carcinoma (HCC) and HCC recurrence remains the primary threat to outcomes after curative therapy. In this study, we compared recurrent and nonrecurrent HCC patients treated with radiofrequency ablation (RFA) in order to identify characteristic metabolic profile variations associated with HCC recurrence. Gas chromatography-mass spectrometry (GC-MS) -based metabolomic analyses were conducted on serum samples obtained before and after RFA therapy. Significant variations were observed in metabolites in the glycerolipid, tricarboxylic acid (TCA) cycle, fatty acid, and amino acid pathways between recurrent and non-recurrent patients. Observed differences in metabolites associated with recurrence did not coincide before and after treatment except for fatty acids. Based on the comparison of serum metabolomes between recurrent and non-recurrent patients, key discriminatory metabolites were defined by a random forest (RF) test. Two combinations of these metabolites before and after RFA treatment showed outstanding performance in predicting HCV-related HCC recurrence, they were further confirmed by an external validation set. Our study showed that the determined combination of metabolites may be potential biomarkers for the prediction of HCC recurrence before and after RFA treatment. © Liu et al.
https://hal-univ-evry.archives-ouvertes.fr/hal-02489935
Contributor : Univ Évry Hal Connect in order to contact the contributor
Submitted on : Monday, February 24, 2020 - 5:40:21 PM
Last modification on : Tuesday, January 4, 2022 - 5:06:45 AM
Contributor : Univ Évry Hal Connect in order to contact the contributor
Submitted on : Monday, February 24, 2020 - 5:40:21 PM
Last modification on : Tuesday, January 4, 2022 - 5:06:45 AM
Links full text
